JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Study at a glance
Characteristics
Peer reviewed
Citations
3
Key finding
Novel indoline derivatives act as serotonergic psychedelic agents for treating psychosis, mental illness, and CNS disorders.
Abstract
Provided herein are novel indoline derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders and processes for preparing such compounds.
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS medicinal chemistry letters
June 12, 2025
4 citations
via PubMed
Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.
ACS Med Chem Lett
April 27, 2026
via PubMed Central
Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder.
ACS medicinal chemistry letters
January 9, 2025
7 citations
via PubMed
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS Med Chem Lett
January 4, 2025
via PubMed Central
Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders.
ACS Med Chem Lett
February 11, 2025
via PubMed Central
© 2026 Mindscape Collective
Support Our Mission
Choose your preferred way to support Mindscape Collective's work in advancing consciousness research.